Recombinant Anti-Human XAGE1B Antibody Fab Fragment
CAT#: MOB-2212z-F(E)
Recombinant Mouse Antibody Fab Fragment binds selectively to Human XAGE1B, expressed in Chinese Hamster Ovary cells(CHO).
Gene Expression
Subcellular Location and Protein Expression
Figure 1 IF staining of human cell line U-2 OS
Immunofluorescent staining of human cell line U-2 OS shows localization to nucleoplasm.
* Image credit: Image credit: Human Protein Atlas v21.proteinatlas.org/images/46363/981_G10_2_selected.jpg
RNA Expression
Figure 2 RNA cell line category: Cell line enhanced (HMC-1, NB-4, THP-1, U-2 OS, U-266/84, U-937)
Cell lines ordered by descending RNA expression order.
* Image credit: Image credit: Human Protein Atlas v21.proteinatlas.org/ENSG00000204382-XAGE1B/subcellular
❮
❯
Specifications
- Immunogen
- Human X Antigen Family, Member 1B
- Host Species
- Mouse
- Derivation
- Mouse
- Type
- Fab
- Specificity
- Tested positive against native Human X Antigen Family, Member 1B
- Species Reactivity
- Human
- Applications
- Formats of immunological tests: Enzyme-linked Immunosorbent Assay; Nert; Functional Study
Product Property
- Purity
- >95% (SDS-PAGE)
- Storage
- Short Term Storage: 4°C
Long Term Storage: -20°C
Target
- Alternative Names
- XAGE1B; CT12.1B; Protein XAGE-1; Cancer/Testis Antigen 12.1; Cancer/Testis Antigen Family 12; XAGE-1; Cancer/Testis Antigen Family 12, Member 1a; CT12.1A; XAGE1A XAGE1B XAGE1C XAGE1D XAGE1E; G Antigen Family D Member 2; XAGE1A; X Antigen Family, Member 1B
- Gene ID
- 653220
- UniProt ID
- Q9HD64
REVIEWS AND Q&AS
CITATIONS
RESOURCES
DOWNLOADS
RELATED PRODUCTS
Inquiry
Navs
Customer Review
There are currently no Customer reviews or questions for MOB-2212z-F(E). Click the button above to contact us or submit your feedback about this product.
Submit Your Publication
Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.
Downloadable Resources
Download resources about recombinant antibody development and antibody engineering to boost your research.
Product Notes
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Datasheet
MSDS
COA
Certificate of Analysis LookupTo download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number:
See other products for "XAGE1B"
Select a product category from the dropdown menu below to view related products.
| CAT | Product Name | Application | Type |
|---|---|---|---|
| MOB-2212z | Recombinant Anti-Human XAGE1B Antibody | WB, FC, FuncS | IgG |
| MOB-2217z | Mouse Anti-XAGE1B Recombinant Antibody (MOB-2217z) | ELISA, Western Blot | Mouse IgG1, κ |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| MOB-2212z-S(P) | Recombinant Anti-Human XAGE1B Antibody scFv Fragment | ELISA, WB, Neut, FuncS | scFv |
Specific Inquiry
Add to compare
See Our Custom Production in Action
Popular Products
Application: Neut, ELISA, IF, IP, FuncS, FC, ICC
Application: ELISA, IP, FC, FuncS, Neut, IF, WB
Application: WB, ELISA, FC, IP, FuncS, IF, Neut
Application: ELISA, IP, FC, FuncS, Neut, IF, IHC
Application: Neut, ELISA, IF, IP, FuncS, FC, ICC
Application: FC, IP, ELISA, Neut, FuncS, IF, WB
Application: Neut, ELISA, IF, IP, FuncS, FC, WB
Application: WB, Neut, ELISA, IF, IP, FuncS, FC
Application: WB, ELISA, FuncS
Application: WB, ELISA, Neut, FuncS
Application: ELISA, FuncS, Neut, IF, WB, EM, Inhib, IHC
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
